Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related AXS
AXIS Capital and PartnerRe Announce HSR Clearance for Amalgamation
Earnings Scheduled For February 3, 2015
AXIS Capital Holdings' (AXS) CEO Albert Benchimol Q1 2015 Results - Earnings Call Transcript (Seeking Alpha)
Related THRX
Morning Market Losers
18 Biotech Stocks These Wall Street Analysts Are Tracking
GlaxoSmithKline And Theravance: The Asthma Approval In Figures (Seeking Alpha)

Analysts at Goldman Sachs downgraded Axis Capital Holdings (NYSE: AXS) from “neutral” to “sell.” The target price for Axis Capital has been lowered from $44 to $43. Axis Capital's shares closed at $46.34 yesterday.

Stifel Nicolaus downgraded Theravance (NASDAQ: THRX) from “buy” to “hold” and removed the price target of $37.86. Theravance's shares closed at $26.40 yesterday.

Sterne Agee downgraded SpringLeaf Holdings (NYSE: LEAF) from “buy” to “neutral.” The target price for SpringLeaf has been lowered from $30 to $28. SpringLeaf's shares closed at $26.49 yesterday.

Analysts at KeyBanc downgraded Computer Programs and Systems (NASDAQ: CPSI) from “hold” to “underweight.” The price target for Computer Programs is set to $55. Computer Programs' shares closed at $65.70 yesterday.

Latest Ratings for AXS

DateFirmActionFromTo
Apr 2015JMP SecuritiesMaintainsMarket Outperform
Apr 2015Deutsche BankMaintainsHold
Feb 2015CitigroupMaintainsNeutral

View More Analyst Ratings for AXS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (CPSI + AXS)

Around the Web, We're Loving...